HEADER TRANSFERASE 27-AUG-23 8QCN TITLE E.COLI ISPE IN COMPLEX WITH A LIGAND (2) COMPND MOL_ID: 1; COMPND 2 MOLECULE: 4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTHRITOL KINASE; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 GENE: ISPE; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS E. COLI, ISPE, INHIBITOR, COMPLEX., KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR R.HAMID REVDAT 1 11-SEP-24 8QCN 0 JRNL AUTH R.HAMID JRNL TITL E.COLI ISPE IN COMPLEX WITH A LIGAND (2) JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.86 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.86 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.95 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 84.4 REMARK 3 NUMBER OF REFLECTIONS : 39541 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.229 REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.160 REMARK 3 FREE R VALUE TEST SET COUNT : 2040 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.9500 - 4.5800 0.99 3052 158 0.1636 0.1900 REMARK 3 2 4.5800 - 3.6300 0.99 2943 171 0.1587 0.1989 REMARK 3 3 3.6300 - 3.1700 1.00 2943 181 0.2021 0.2466 REMARK 3 4 3.1700 - 2.8800 1.00 2964 174 0.2437 0.3029 REMARK 3 5 2.8800 - 2.6800 0.99 2912 174 0.2588 0.3155 REMARK 3 6 2.6800 - 2.5200 0.99 2910 161 0.2630 0.3118 REMARK 3 7 2.5200 - 2.3900 0.99 2912 155 0.2710 0.3470 REMARK 3 8 2.3900 - 2.2900 0.98 2900 165 0.2998 0.3578 REMARK 3 9 2.2900 - 2.2000 0.97 2834 158 0.3836 0.4241 REMARK 3 10 2.2000 - 2.1200 0.96 2815 158 0.3789 0.4169 REMARK 3 11 2.1200 - 2.0600 0.88 2626 119 0.4046 0.3745 REMARK 3 12 2.0600 - 2.0000 0.80 2375 115 0.4239 0.4381 REMARK 3 13 2.0000 - 1.9500 0.51 1527 54 0.4659 0.4059 REMARK 3 14 1.9500 - 1.9000 0.57 1539 84 0.5082 0.5358 REMARK 3 15 1.8900 - 1.8600 0.09 249 13 0.5362 0.5179 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.385 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 40.530 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 39.28 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 48.57 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 4524 REMARK 3 ANGLE : 0.664 6173 REMARK 3 CHIRALITY : 0.041 694 REMARK 3 PLANARITY : 0.005 793 REMARK 3 DIHEDRAL : 14.797 637 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 28.9172 0.7690 17.3192 REMARK 3 T TENSOR REMARK 3 T11: 0.4650 T22: 0.2474 REMARK 3 T33: 0.2314 T12: -0.0049 REMARK 3 T13: -0.0425 T23: -0.0072 REMARK 3 L TENSOR REMARK 3 L11: 1.0963 L22: 0.4804 REMARK 3 L33: 0.1962 L12: 0.2358 REMARK 3 L13: -0.1902 L23: -0.1039 REMARK 3 S TENSOR REMARK 3 S11: -0.0165 S12: 0.0384 S13: -0.0121 REMARK 3 S21: 0.0315 S22: -0.0054 S23: 0.0000 REMARK 3 S31: 0.0151 S32: 0.0128 S33: 0.0221 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8QCN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 29-AUG-23. REMARK 100 THE DEPOSITION ID IS D_1292132934. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-APR-23 REMARK 200 TEMPERATURE (KELVIN) : 80 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID30B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.62 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 X 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45832 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.860 REMARK 200 RESOLUTION RANGE LOW (A) : 45.950 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 2.400 REMARK 200 R MERGE (I) : 0.05800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.86 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.93 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.68000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX 1.20.1_4487 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.27 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG 4K; 200MM MGCL2; 100MM MES PH REMARK 280 6.5, VAPOR DIFFUSION, TEMPERATURE 291.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 71.96400 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 26.55650 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 71.96400 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 26.55650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET B 1 REMARK 465 MET B 282 REMARK 465 LEU B 283 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP B 141 H121 QB9 B 302 1.59 REMARK 500 O ALA A 246 O HOH A 401 1.95 REMARK 500 O LEU A 171 O HOH A 401 2.11 REMARK 500 O HOH B 434 O HOH B 448 2.16 REMARK 500 O HOH B 454 O HOH B 455 2.17 REMARK 500 O HOH B 445 O HOH B 447 2.18 REMARK 500 OD1 ASP B 141 N12 QB9 B 302 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 37 138.56 177.42 REMARK 500 GLU A 154 -166.22 -128.75 REMARK 500 TYR B 37 123.78 -174.76 REMARK 500 GLU B 154 -153.70 -125.17 REMARK 500 PRO B 175 4.87 -68.84 REMARK 500 ASN B 193 23.99 -140.29 REMARK 500 REMARK 500 REMARK: NULL DBREF 8QCN A 1 283 UNP B7LXC3 ISPE_ECO8A 1 283 DBREF 8QCN B 1 283 UNP B7LXC3 ISPE_ECO8A 1 283 SEQADV 8QCN VAL A 100 UNP B7LXC3 MET 100 CONFLICT SEQADV 8QCN VAL B 100 UNP B7LXC3 MET 100 CONFLICT SEQRES 1 A 283 MET ARG THR GLN TRP PRO SER PRO ALA LYS LEU ASN LEU SEQRES 2 A 283 PHE LEU TYR ILE THR GLY GLN ARG ALA ASP GLY TYR HIS SEQRES 3 A 283 THR LEU GLN THR LEU PHE GLN PHE LEU ASP TYR GLY ASP SEQRES 4 A 283 THR ILE SER ILE GLU LEU ARG ASP ASP GLY ASP ILE ARG SEQRES 5 A 283 LEU LEU THR PRO VAL GLU GLY VAL GLU HIS GLU ASP ASN SEQRES 6 A 283 LEU ILE VAL ARG ALA ALA ARG LEU LEU MET LYS THR ALA SEQRES 7 A 283 ALA ASP SER GLY ARG LEU PRO THR GLY SER GLY ALA ASN SEQRES 8 A 283 ILE SER ILE ASP LYS ARG LEU PRO VAL GLY GLY GLY LEU SEQRES 9 A 283 GLY GLY GLY SER SER ASN ALA ALA THR VAL LEU VAL ALA SEQRES 10 A 283 LEU ASN HIS LEU TRP GLN CYS GLY LEU SER MET ASP GLU SEQRES 11 A 283 LEU ALA GLU MET GLY LEU THR LEU GLY ALA ASP VAL PRO SEQRES 12 A 283 VAL PHE VAL ARG GLY HIS ALA ALA PHE ALA GLU GLY VAL SEQRES 13 A 283 GLY GLU ILE LEU THR PRO VAL ASP PRO PRO GLU LYS TRP SEQRES 14 A 283 TYR LEU VAL ALA HIS PRO GLY VAL SER ILE PRO THR PRO SEQRES 15 A 283 VAL ILE PHE LYS ASP PRO GLU LEU PRO ARG ASN THR PRO SEQRES 16 A 283 LYS ARG SER ILE GLU THR LEU LEU LYS CYS GLU PHE SER SEQRES 17 A 283 ASN ASP CYS GLU VAL ILE ALA ARG LYS ARG PHE ARG GLU SEQRES 18 A 283 VAL ASP ALA VAL LEU SER TRP LEU LEU GLU TYR ALA PRO SEQRES 19 A 283 SER ARG LEU THR GLY THR GLY ALA CYS VAL PHE ALA GLU SEQRES 20 A 283 PHE ASP THR GLU SER GLU ALA ARG GLN VAL LEU GLU GLN SEQRES 21 A 283 ALA PRO GLU TRP LEU ASN GLY PHE VAL ALA LYS GLY VAL SEQRES 22 A 283 ASN LEU SER PRO LEU HIS ARG ALA MET LEU SEQRES 1 B 283 MET ARG THR GLN TRP PRO SER PRO ALA LYS LEU ASN LEU SEQRES 2 B 283 PHE LEU TYR ILE THR GLY GLN ARG ALA ASP GLY TYR HIS SEQRES 3 B 283 THR LEU GLN THR LEU PHE GLN PHE LEU ASP TYR GLY ASP SEQRES 4 B 283 THR ILE SER ILE GLU LEU ARG ASP ASP GLY ASP ILE ARG SEQRES 5 B 283 LEU LEU THR PRO VAL GLU GLY VAL GLU HIS GLU ASP ASN SEQRES 6 B 283 LEU ILE VAL ARG ALA ALA ARG LEU LEU MET LYS THR ALA SEQRES 7 B 283 ALA ASP SER GLY ARG LEU PRO THR GLY SER GLY ALA ASN SEQRES 8 B 283 ILE SER ILE ASP LYS ARG LEU PRO VAL GLY GLY GLY LEU SEQRES 9 B 283 GLY GLY GLY SER SER ASN ALA ALA THR VAL LEU VAL ALA SEQRES 10 B 283 LEU ASN HIS LEU TRP GLN CYS GLY LEU SER MET ASP GLU SEQRES 11 B 283 LEU ALA GLU MET GLY LEU THR LEU GLY ALA ASP VAL PRO SEQRES 12 B 283 VAL PHE VAL ARG GLY HIS ALA ALA PHE ALA GLU GLY VAL SEQRES 13 B 283 GLY GLU ILE LEU THR PRO VAL ASP PRO PRO GLU LYS TRP SEQRES 14 B 283 TYR LEU VAL ALA HIS PRO GLY VAL SER ILE PRO THR PRO SEQRES 15 B 283 VAL ILE PHE LYS ASP PRO GLU LEU PRO ARG ASN THR PRO SEQRES 16 B 283 LYS ARG SER ILE GLU THR LEU LEU LYS CYS GLU PHE SER SEQRES 17 B 283 ASN ASP CYS GLU VAL ILE ALA ARG LYS ARG PHE ARG GLU SEQRES 18 B 283 VAL ASP ALA VAL LEU SER TRP LEU LEU GLU TYR ALA PRO SEQRES 19 B 283 SER ARG LEU THR GLY THR GLY ALA CYS VAL PHE ALA GLU SEQRES 20 B 283 PHE ASP THR GLU SER GLU ALA ARG GLN VAL LEU GLU GLN SEQRES 21 B 283 ALA PRO GLU TRP LEU ASN GLY PHE VAL ALA LYS GLY VAL SEQRES 22 B 283 ASN LEU SER PRO LEU HIS ARG ALA MET LEU HET ADP A 301 39 HET QB9 A 302 30 HET ADP B 301 39 HET QB9 B 302 30 HETNAM ADP ADENOSINE-5'-DIPHOSPHATE HETNAM QB9 ~{N}-[3-(4-AZANYL-2-OXIDANYLIDENE-1~{H}-PYRIMIDIN-5- HETNAM 2 QB9 YL)PROP-2-YNYL]CYCLOPROPANESULFONAMIDE HETSYN QB9 N-(3-(4-AMINO-2-OXO-1,2-DIHYDROPYRIMIDIN-5-YL)PROP-2- HETSYN 2 QB9 YN-1-YL)CYCLOPROPANESULFONAMIDE FORMUL 3 ADP 2(C10 H15 N5 O10 P2) FORMUL 4 QB9 2(C10 H12 N4 O3 S) FORMUL 7 HOH *103(H2 O) HELIX 1 AA1 GLU A 61 ASP A 64 5 4 HELIX 2 AA2 ASN A 65 ASP A 80 1 16 HELIX 3 AA3 GLY A 105 TRP A 122 1 18 HELIX 4 AA4 SER A 127 GLY A 139 1 13 HELIX 5 AA5 ASP A 141 GLY A 148 1 8 HELIX 6 AA6 PRO A 180 ASP A 187 1 8 HELIX 7 AA7 SER A 198 CYS A 205 1 8 HELIX 8 AA8 CYS A 211 PHE A 219 1 9 HELIX 9 AA9 PHE A 219 GLU A 231 1 13 HELIX 10 AB1 THR A 250 GLN A 260 1 11 HELIX 11 AB2 PRO A 262 LEU A 265 5 4 HELIX 12 AB3 SER A 276 LEU A 283 1 8 HELIX 13 AB4 GLU B 61 ASP B 64 5 4 HELIX 14 AB5 ASN B 65 ASP B 80 1 16 HELIX 15 AB6 GLY B 105 TRP B 122 1 18 HELIX 16 AB7 SER B 127 GLY B 139 1 13 HELIX 17 AB8 ASP B 141 GLY B 148 1 8 HELIX 18 AB9 PRO B 180 LYS B 186 1 7 HELIX 19 AC1 SER B 198 CYS B 205 1 8 HELIX 20 AC2 CYS B 211 PHE B 219 1 9 HELIX 21 AC3 PHE B 219 GLU B 231 1 13 HELIX 22 AC4 THR B 250 GLN B 260 1 11 HELIX 23 AC5 PRO B 262 ASN B 266 5 5 HELIX 24 AC6 SER B 276 ALA B 281 1 6 SHEET 1 AA1 4 ARG A 2 GLN A 20 0 SHEET 2 AA1 4 HIS A 26 ARG A 46 -1 O GLN A 33 N LEU A 11 SHEET 3 AA1 4 ALA A 151 GLU A 154 -1 O ALA A 151 N PHE A 32 SHEET 4 AA1 4 ILE A 159 PRO A 162 -1 O THR A 161 N PHE A 152 SHEET 1 AA2 7 ILE A 51 LEU A 53 0 SHEET 2 AA2 7 GLY A 89 ASP A 95 1 O ILE A 92 N ARG A 52 SHEET 3 AA2 7 HIS A 26 ARG A 46 -1 N GLU A 44 O ASN A 91 SHEET 4 AA2 7 GLY A 267 VAL A 273 -1 O LYS A 271 N ASP A 36 SHEET 5 AA2 7 TRP A 169 ALA A 173 -1 N VAL A 172 O PHE A 268 SHEET 6 AA2 7 VAL A 244 PHE A 248 -1 O VAL A 244 N ALA A 173 SHEET 7 AA2 7 SER A 235 LEU A 237 -1 N ARG A 236 O PHE A 245 SHEET 1 AA3 4 THR B 3 GLN B 20 0 SHEET 2 AA3 4 HIS B 26 ARG B 46 -1 O ILE B 41 N TRP B 5 SHEET 3 AA3 4 ALA B 151 GLU B 154 -1 O ALA B 153 N THR B 30 SHEET 4 AA3 4 ILE B 159 PRO B 162 -1 O THR B 161 N PHE B 152 SHEET 1 AA4 7 ILE B 51 LEU B 53 0 SHEET 2 AA4 7 GLY B 89 ASP B 95 1 O ILE B 92 N ARG B 52 SHEET 3 AA4 7 HIS B 26 ARG B 46 -1 N SER B 42 O SER B 93 SHEET 4 AA4 7 PHE B 268 VAL B 273 -1 O LYS B 271 N ASP B 36 SHEET 5 AA4 7 TRP B 169 ALA B 173 -1 N VAL B 172 O PHE B 268 SHEET 6 AA4 7 VAL B 244 PHE B 248 -1 O VAL B 244 N ALA B 173 SHEET 7 AA4 7 SER B 235 LEU B 237 -1 N ARG B 236 O PHE B 245 CISPEP 1 GLY A 241 ALA A 242 0 3.88 CISPEP 2 GLY B 241 ALA B 242 0 1.30 CRYST1 143.928 53.113 91.717 90.00 127.39 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006948 0.000000 0.005310 0.00000 SCALE2 0.000000 0.018828 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013723 0.00000